U.S. market Closed. Opens in 5 hours 48 minutes

ACER | Acer Therapeutics Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.6601 - 0.8500
52 Week Range 0.5500 - 4.56
Beta 0.48
Implied Volatility 578.88%
IV Rank 34.15%
Day's Volume 574,675
Average Volume 2,387,245
Shares Outstanding N/A
Market Cap 20,796,613
Sector Healthcare
Industry Biotechnology
IPO Date 2004-04-14
Valuation
Profitability
Growth
Health
P/E Ratio -0.34
Forward P/E Ratio N/A
EPS -1.93
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 30
Country USA
Website ACER
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts.
ACER's peers: MNKD
*Chart delayed
Analyzing fundamentals for ACER we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ACER Fundamentals page.

Watching at ACER technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ACER Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙